Personalized immune cell therapy for solid tumors
Part of Cancer clinical trials.
This trial tests a personalized cell therapy (tumor polypeptide DC-CTL) for adults with solid tumors such as colorectal, lung, or breast cancer. The goal is to see if infusing your own immune cells trained to attack cancer can help control the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older, with any solid tumor like colorectal, lung, breast, liver, or esophageal cancer.
- You are able to do most daily activities on your own (KPS score of 80 or higher).
- You have at least one tumor that can be measured on a scan (at least 1 cm).
- Your liver, kidney, and blood tests show acceptable function (within certain limits).
- You do not have a serious autoimmune disease, active infection, or have had gene therapy before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests personalized immune cells (T cells) made from your own tumor and blood to treat advanced solid cancers. It may help your immune system recognize and attack your tumor, especially if standard treatments no longer work.
This trial tests a personalized cancer vaccine made from your own immune cells to help your body fight the tumor. It is for people with solid tumors that have not responded to other treatments.
This trial tests a treatment that takes immune cells from your tumor, multiplies them in a lab, and gives them back to you to fight the cancer. It is for people with advanced solid tumors who have tried other treatments or cannot have them.
This study tests a new treatment using your body's own immune cells (called tumor-infiltrating lymphocytes) that are taken from your tumor, grown in a lab, and then put back into you. It's for people with advanced solid tumors who have run out of standard options.
This Phase 1 study tests engineered immune cells (TILs/CAR-TILs) made from your tumor to treat advanced solid cancers that have not responded to standard treatments. It may help your immune system better recognize and attack the cancer, but it is mainly focused on safety and early results.
This trial tests a personalized therapy made from your own immune cells. Doctors will take a sample of your tumor, find cells that recognize your cancer, grow them in the lab, and give them back to you to fight your advanced solid tumor that has not responded to other treatments.
Hear when a new Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.